Medications for Hemochromatosis

9 results

  • deferasirox

    (Deferasirox)
    Teva Pharmaceuticals Inc
    Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.

  • deferasirox

    (DEFERASIROX)
    Alembic Pharmaceuticals Limited
    Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients aged 2 years and older. The safety and efficacy of this drug with other iron chelation therapies are not established.

  • deferasirox

    (deferasirox)
    Bionpharma Inc.
    Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.

  • deferasirox

    (Deferasirox)
    Ascend Laboratories, LLC
    Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.

  • deferasirox

    (DEFERASIROX)
    Zydus Pharmaceuticals USA Inc.
    Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration and serum ferritin levels.

  • deferasirox

    (Deferasirox)
    Actavis Pharma, Inc.
    Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.

  • deferasirox oral granules

    (deferasirox)
    EPIC PHARMA, LLC
    Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.

  • deferasorox

    (Deferasirox)
    MSN LABORATORIES PRIVATE LIMITED
    Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.

  • deferasorox

    (Deferasirox)
    Novadoz Pharmaceuticals LLC
    Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, as well as for those aged 10 and older with non-transfusion dependent thalassemia syndromes, if specific liver iron concentration and serum ferritin levels are met.